Literature DB >> 30586774

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Scott M Grundy1, Neil J Stone1, Alison L Bailey1, Craig Beam1, Kim K Birtcher1, Roger S Blumenthal1, Lynne T Braun1, Sarah de Ferranti1, Joseph Faiella-Tommasino1, Daniel E Forman1, Ronald Goldberg1, Paul A Heidenreich1, Mark A Hlatky1, Daniel W Jones1, Donald Lloyd-Jones1, Nuria Lopez-Pajares1, Chiadi E Ndumele1, Carl E Orringer1, Carmen A Peralta1, Joseph J Saseen1, Sidney C Smith1, Laurence Sperling1, Salim S Virani1, Joseph Yeboah1.   

Abstract

Entities:  

Keywords:  AHA Scientific Statements; Guidelines; biomarkers, coronary artery calcium score; cardiovascular disease; cholesterol, LDL-cholesterol; diabetes mellitus; drug therapy; ezetimibe; hydroxymethylglutaryl-CoA reductase inhibitors/statins; hypercholesterolemia; lipids; patient compliance; pharmacological; primary prevention; proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9) inhibitors; risk assessment; risk reduction discussion; risk treatment discussion, secondary prevention

Mesh：

Substances：

Year:  2018        PMID： 30586774     DOI： 10.1161/CIR.0000000000000625

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  572 in total

1.  High prevalence of plasma lipid abnormalities in human and canine Duchenne and Becker muscular dystrophies depicts a new type of primary genetic dyslipidemia.

Authors:  Zoe White; Chady H Hakim; Marine Theret; N Nora Yang; Fabio Rossi; Dan Cox; Gordon A Francis; Volker Straub; Kathryn Selby; Constadina Panagiotopoulos; Dongsheng Duan; Pascal Bernatchez
Journal:  J Clin Lipidol       Date:  2020-05-29       Impact factor: 4.766

Review 2.  Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence.

Authors:  Hong Sheng Cheng; Wei Ren Tan; Zun Siong Low; Charlie Marvalim; Justin Yin Hao Lee; Nguan Soon Tan
Journal:  Int J Mol Sci       Date:  2019-10-11       Impact factor: 5.923

3.  Effect of Continuing Olanzapine vs Placebo on Relapse Among Patients With Psychotic Depression in Remission: The STOP-PD II Randomized Clinical Trial.

Authors:  Alastair J Flint; Barnett S Meyers; Anthony J Rothschild; Ellen M Whyte; George S Alexopoulos; Matthew V Rudorfer; Patricia Marino; Samprit Banerjee; Cristina D Pollari; Yiyuan Wu; Aristotle N Voineskos; Benoit H Mulsant
Journal:  JAMA       Date:  2019-08-20       Impact factor: 56.272

Review 4.  Lp(a): Addressing a Target for Cardiovascular Disease Prevention.

Authors:  Nestor Vasquez; Parag H Joshi
Journal:  Curr Cardiol Rep       Date:  2019-07-31       Impact factor: 2.931

Review 5.  Current management of non-alcoholic steatohepatitis.

Authors:  Mark D Muthiah; Arun J Sanyal
Journal:  Liver Int       Date:  2020-02       Impact factor: 5.828

Review 6.  Should We Target Global Risk or Risk Factors?

Authors:  Lale Tokgozoglu; Duygu Kocyigit
Journal:  Curr Atheroscler Rep       Date:  2021-01-03       Impact factor: 5.113

7.  Effect of Evolocumab on Atherogenic Lipoproteins During the Peri- and Early Postinfarction Period: A Placebo-Controlled, Randomized Trial.

Authors:  Thorsten M Leucker; Michael J Blaha; Steven R Jones; Michael A Vavuranakis; Marlene S Williams; Hong Lai; Thomas H Schindler; Jacqueline Latina; Steven P Schulman; Gary Gerstenblith
Journal:  Circulation       Date:  2020-07-27       Impact factor: 29.690

8.  Sex differences in the manifestation and evolution of coronary artery plaques.

Authors:  Benedikt Bernhard; Christoph Gräni
Journal:  Int J Cardiovasc Imaging       Date:  2021-05-11       Impact factor: 2.357

Review 9.  The Use of Sex-Specific Factors in the Assessment of Women's Cardiovascular Risk.

Authors:  Anandita Agarwala; Erin D Michos; Zainab Samad; Christie M Ballantyne; Salim S Virani
Journal:  Circulation       Date:  2020-02-17       Impact factor: 29.690

10.  Association Between the Framingham Risk Score and Carotid Artery Intima-Media Thickness in Patients With Human Immunodeficiency Virus.

Authors:  Kyari Sumayin Ngamdu; Omosalewa O Adewale; Indika Mallawaarachchi; Ogechika K Alozie; Alok K Dwivedi; Deepak L Bhatt
Journal:  Am J Cardiol       Date:  2020-04-22       Impact factor: 2.778
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.